These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9066029)
1. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model. Woody MA; Krakauer T; Stiles BG Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice. Savransky V; Pinelis D; Korolev S; Ionin B; Fegeding K Toxicon; 2004 Mar; 43(4):433-8. PubMed ID: 15051407 [TBL] [Abstract][Full Text] [Related]
3. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. Woody MA; Krakauer T; Ulrich RG; Stiles BG J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976 [TBL] [Abstract][Full Text] [Related]
4. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus. Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines. Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226 [TBL] [Abstract][Full Text] [Related]
6. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Nagaki M; Muto Y; Ohnishi H; Yasuda S; Sano K; Naito T; Maeda T; Yamada T; Moriwaki H Gastroenterology; 1994 Feb; 106(2):450-8. PubMed ID: 8299910 [TBL] [Abstract][Full Text] [Related]
7. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model. Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755 [TBL] [Abstract][Full Text] [Related]
8. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381 [TBL] [Abstract][Full Text] [Related]
9. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B. Hudson Reichenberg LC; Garg R; Fernalld R; Bost KL; Piller KJ Toxicon; 2017 Jul; 133():82-90. PubMed ID: 28478060 [TBL] [Abstract][Full Text] [Related]
10. Persistent production of TH2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice. Florquin S; Amraoui Z; Goldman M J Autoimmun; 1996 Oct; 9(5):609-15. PubMed ID: 8933276 [TBL] [Abstract][Full Text] [Related]
11. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B. Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905 [TBL] [Abstract][Full Text] [Related]
15. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. LeClaire RD; Hunt RE; Bavari S Infect Immun; 2002 May; 70(5):2278-81. PubMed ID: 11953360 [TBL] [Abstract][Full Text] [Related]
16. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Harris TO; Grossman D; Kappler JW; Marrack P; Rich RR; Betley MJ Infect Immun; 1993 Aug; 61(8):3175-83. PubMed ID: 8335347 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response. Lussow AR; MacDonald HR Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694 [TBL] [Abstract][Full Text] [Related]
18. Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay. Cook E; Wang X; Robiou N; Fries BC Clin Vaccine Immunol; 2007 Sep; 14(9):1094-101. PubMed ID: 17634506 [TBL] [Abstract][Full Text] [Related]
19. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model. Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806 [TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]